Hyperplasia - 133 Studies Found
| Completed |
: Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia :
: 1999-11-03 :
|
| Recruiting |
: Prenatal Dex Study : Congenital Adrenal Hyperplasia : 2016-05-25 : Behavioral: Neuropsychological and cognitive assessment |
| Completed |
: Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets : Congenital Adrenal Hyperplasia : 1999-11-03 : Drug: Nifedipine |
| Recruiting |
: A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH : Congenital Adrenal Hyperplasia : 2016-08-22 : Drug: Hydrocortisone Modified release hydrocortisone |
| Completed |
: Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia :
|
| Completed |
: Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia :
|
| Active, not recruiting |
: A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease : Multicentric Castleman's Disease : 2011-04-21 : Drug: Siltuximab Type=exact number, unit=mg/kg, number=11, form=intravenous solution, route=intravenous. |
| Completed |
: A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment : Castleman's Disease : 2010-08-13 : Drug: tocilizumab [RoActemra/Actemra] maintenance dose |
| Active, not recruiting |
: A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease : Multicentric Castleman's Disease : 2009-11-30 :
|
| Withdrawn |
: Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease : Giant Lymph Node Hyperplasia : 2006-08-08 : Drug: Valganciclovir valganciclovir open label, two 450mg tablets orally, twice a day |